Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
dexamethasone sodium phosphate + lidocaine hydrochloride + povidone-iodine + isopropyl alcohol
- Development stage
- Unknown
- Lead developer
- Enovachem
- Modality
- Small Molecules
- Administration
- Intramuscular, Intravenous, Intraarticular, Intralesional, Topical
01
Overview
This drug is a **small-molecule combination procedural kit** containing dexamethasone sodium phosphate injection, lidocaine hydrochloride injection, povidone-iodine swabsticks, and isopropyl alcohol prep pads. The therapeutic pharmacology is driven primarily by dexamethasone sodium phosphate, a rapidly acting water-soluble synthetic glucocorticoid ester that exerts anti-inflammatory effects through activation of the glucocorticoid receptor and downstream transcriptional regulation, and by lidocaine hydrochloride, a local anesthetic that blocks voltage-gated sodium channels to inhibit nerve impulse conduction. Povidone-iodine and isopropyl alcohol serve as topical antiseptic skin-preparation components rather than systemic therapeutic agents. The product has been marketed as Dexlido and distributed by Enovachem Pharmaceuticals for use as a packaged kit accompanying dexamethasone and lidocaine injection administration across labeled corticosteroid-responsive and procedural-use settings.
- Brand names
- Dexlido
- Other names
- dexamethasone sodium phosphate + lidocaine hydrochloride + povidone-iodine + isopropyl alcoholdexamethasone sodium phosphate injection + lidocaine hydrochloride injection + povidone-iodine + isopropyl alcoholdexamethasone sodium phosphate + lidocaine hydrochloride procedural kit
02
Targets
GR (Glucocorticoid receptor)NaV (Voltage-gated sodium channels)
Beyond the preview
Go deeper on dexamethasone sodium phosphate + lidocaine hydrochloride + povidone-iodine + isopropyl alcohol.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on dexamethasone sodium phosphate + lidocaine hydrochloride + povidone-iodine + isopropyl alcohol.